Clinical Study

Ucci-Brain-16-01- Feasibility Study Of Modified Atkins Ketogenic Diet In The Treatment Of Newly Diagnosed Malignant Glioma

Posted Date: May 15, 2019

  • Investigator: Rekha Chaudhary
  • Specialties: Cancer, Oncology
  • Type of Study: Drug

The goal of this study is to assess the feasibility of inducing ketosis with MAD concurrent with radiation therapy by measuring serum beta-hydroxybuterate.

Criteria:

To Be Eligible: Patients Must Be 18+ Years Of Age And Have A High Grade Glioma (Brain Tumor). Life Expectancy >3 Months. No Other Uncontrolled Infection/Malignancy. Nonpregnant And Nonbreastfeeding.

Keywords:

Brain Cancer, Malignant Glioma, Glioma , Ucci-Brain-16-01

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.